Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

286 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer.
Zhu CS, Pinsky PF, Cramer DW, Ransohoff DF, Hartge P, Pfeiffer RM, Urban N, Mor G, Bast RC Jr, Moore LE, Lokshin AE, McIntosh MW, Skates SJ, Vitonis A, Zhang Z, Ward DC, Symanowski JT, Lomakin A, Fung ET, Sluss PM, Scholler N, Lu KH, Marrangoni AM, Patriotis C, Srivastava S, Buys SS, Berg CD; PLCO Project Team. Zhu CS, et al. Among authors: moore le. Cancer Prev Res (Phila). 2011 Mar;4(3):375-83. doi: 10.1158/1940-6207.CAPR-10-0193. Cancer Prev Res (Phila). 2011. PMID: 21372037 Free PMC article.
Methods for etiologic and early marker investigations in the PLCO trial.
Hayes RB, Sigurdson A, Moore L, Peters U, Huang WY, Pinsky P, Reding D, Gelmann EP, Rothman N, Pfeiffer RM, Hoover RN, Berg CD; PLCO Trial Team. Hayes RB, et al. Mutat Res. 2005 Dec 30;592(1-2):147-54. doi: 10.1016/j.mrfmmm.2005.06.013. Epub 2005 Jul 27. Mutat Res. 2005. PMID: 16054167
GSTM1, GSTT1, and GSTP1 polymorphisms and risk of advanced colorectal adenoma.
Moore LE, Huang WY, Chatterjee N, Gunter M, Chanock S, Yeager M, Welch B, Pinsky P, Weissfeld J, Hayes RB. Moore LE, et al. Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1823-7. doi: 10.1158/1055-9965.EPI-05-0037. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 16030123 Clinical Trial.
Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study.
Moore LE, Pfeiffer RM, Poscablo C, Real FX, Kogevinas M, Silverman D, García-Closas R, Chanock S, Tardón A, Serra C, Carrato A, Dosemeci M, García-Closas M, Esteller M, Fraga M, Rothman N, Malats N. Moore LE, et al. Lancet Oncol. 2008 Apr;9(4):359-66. doi: 10.1016/S1470-2045(08)70038-X. Epub 2008 Mar 12. Lancet Oncol. 2008. PMID: 18339581 Free PMC article.
LINE1 methylation levels associated with increased bladder cancer risk in pre-diagnostic blood DNA among US (PLCO) and European (ATBC) cohort study participants.
Andreotti G, Karami S, Pfeiffer RM, Hurwitz L, Liao LM, Weinstein SJ, Albanes D, Virtamo J, Silverman DT, Rothman N, Moore LE. Andreotti G, et al. Among authors: moore le. Epigenetics. 2014 Mar;9(3):404-15. doi: 10.4161/epi.27386. Epub 2013 Dec 6. Epigenetics. 2014. PMID: 24316677 Free PMC article. Clinical Trial.
Measurement of urine pH for epidemiological studies on bladder cancer.
Alguacil J, Pfeiffer RM, Moore LE, Del Fresno MR, Medina-Lopez R, Kogevinas M, Vermeulen R, Dosemeci M, Silverman DT, Rothman N, García-Closas M. Alguacil J, et al. Among authors: moore le. Eur J Epidemiol. 2007;22(2):91-8. doi: 10.1007/s10654-006-9101-2. Epub 2007 Mar 3. Eur J Epidemiol. 2007. PMID: 17334820
286 results